Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus
Soluble Dietary Fibres as Dietetic Aid to Reduce the Risks of Type 2 Diabetes Mellitus
1 other identifier
interventional
60
1 country
1
Brief Summary
Controlling the glycemic impact of foodstuffs (by reducing the glycemic load of the diet by using soluble dietary fibres) may reduce the glycemic or insulinemic response. This may in turn result in a reduced inhibition of postprandial fat oxidation rate and a lower plasma triacylglycerol concentration A higher postprandial fat oxidation may result in less lipid accumulation in non-adipose tissue thereby improving insulin sensitivity and the metabolic profile in the longer term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Mar 2010
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 14, 2010
CompletedFirst Posted
Study publicly available on registry
July 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJanuary 9, 2018
July 1, 2010
1 year
July 14, 2010
January 5, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
fat oxidation
Secondary Outcomes (1)
24h glucose pattern
Study Arms (4)
polydextrose
EXPERIMENTALsoluble glucofibre
EXPERIMENTALisocaloric dietary control
PLACEBO COMPARATORfull caloric control
PLACEBO COMPARATORInterventions
Polydextrose and soluble gluco fibre
Eligibility Criteria
You may qualify if:
- Overweight men and women
You may not qualify if:
- regular smokers, athletes, diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, 6200 MD, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2010
First Posted
July 15, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
January 9, 2018
Record last verified: 2010-07